Article
Using image classifiers to predict CMT2A disease-relevant mitochondrial motility phenotypes in iPSC motor neurons
2026-03-17
Abstract excerpt
<h4>ABSTRACT</h4> Charcot-Marie-Tooth disease type 2A (CMT2A) is a genetic disease characterized by autosomal dominant MFN2 mutations and dysregulated mitochondrial trafficking. While there is currently no FDA-approved CMT2A therapy, the recent development of iPSC motor neuron model systems, high-throughput imaging platforms, and CRISPR-based gene editing technologies holds promise for screening new therapies at...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 454d1a81-de44-5be8-885d-9c61de21ff53
- DOI
- 10.64898/2026.03.16.712192
